Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers March 26, 2017
Pharmacy Choice - News - Pharmaceutical Industry Trends and Policy - March 26, 2017

Pharmacy News

 Pharmaceutical Industry Trends and Policy
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

12/31/15 - AHF: Ohio Certifies Voter Signatures In Support of Drug Pricing Initiative, Clears Hurdle for November Ballot
The Ohio Secretary of State certified yesterday 116,015 signatures of registered Ohio voters who support the Ohio Drug Price Relief Act, a proposed statewide ballot initiative that will revise Ohio law to require state programs pay the same or less for prescription medications as the U.S. Department of Veterans Affairs. Drug pricing advocates affil
12/31/15 - Alexion Pharmaceuticals Assigned Patent
ALEXANDRIA, Va., Dec. 31 Alexion Pharmaceuticals, Cheshire, Connecticut, has been assigned a patent developed by four co-inventors for "methods of treating complement-associated disorders with anti-C5a antibodies." The co-inventors are Russell P. Rother, Oklahoma City, Douglas L. Sheridan, Branford, Connecticut, Paul P. Tamburini, Kensington, Con
12/31/15 - Araim Pharmaceuticals announces a strategic partnership with Vault Bioventures to support development and commercialization of ARA 290 as well as other peptides within a novel family
Araim Pharmaceuticals has formed a long-term strategic partnership with Vault Bioventures to facilitate the advancement to market of its novel peptide library which targets devastating injuries and chronic diseases underserved by current therapies. This new strategic collaboration is expected to leverage the expertise of Araim Pharmaceuticals in.
12/31/15 - Axis Pharmacy 14 - the Leading Pharmacy Software Built to Meet All Needs
Axis Pharmacy 14 is a useful tool developed for the pharmaceutical industry that has user-friendly interface and many valuable features for the growth of the business. It is a flexible application that is designed by considering the requirements of the retailers to provide them an efficient way of running their pharmaceutical business.
12/31/15 - Basilea provides clinical program updates
Release date- 28122015- Basilea Pharmaceutica Ltd. today provided an update on the planned clinical phase 3 development program for its antibiotic ceftobiprole in the United States and reported completion of patient recruitment and interim data from the ongoing phase 1/ 2 a study with the intravenous formulation of its oncology drug candidate BAL10
12/31/15 - Braeburn Pharmaceuticals and Camurus enroll first patient in a phase 3 efficacy trial of long-acting treatment for opioid dependence [Tripoli Post, The (Libya)]
-Princeton, New Jersey and Lund, Sweden 30 December 2015 Braeburn. Pharmaceuticals and Camurus announce that the first patient has been randomized. in the double blind Phase 3 efficacy trial of CAM2038 in opioid-dependent.
12/31/15 - Clovis Oncology Receives Notification of PDUFA Extension for Rociletinib
By a News Reporter-Staff News Editor at Politics& Government Week Clovis Oncology, Inc. announced that the U.S. Food and Drug Administration has extended the Prescription Drug User Fee Act date for Clovis' New Drug Application for rociletinib by the standard extension period of three months with the new goal date of June 28, 2016. Clovis Oncology
12/31/15 - Collegium Pharmaceutical Provides Update on Orange Book-Listed Patent Suits [Global Data Point]
The three patents have been previously invalidated for obviousness by the court in the Southern District of New York in Purdue Pharma, L.P.' s suit against Teva Pharmaceuticals USA, Inc. Purdue appealed the obviousness ruling to the Federal Circuit, which heard oral arguments on November 3, 2015.&# x0D;. Purdue's initiation of a patent infringement
12/31/15 - Community Clinic offering free prescription assistance drug program, Medicare guidance
The Nelson County Community Clinic helps out individuals and families who can't afford prescription medications and make decisions about which Medicare supplement coverage is right for them. Margaret Neel, the prescription benefits coordinator for the free clinic, said it was important that people on Medicare look at their coverage each year.
12/31/15 - Court: Killer's conversations with husband not confidential
Sheila Davalloo, 46, formerly of Pleasantville, New York, tried to prevent her husband from testifying at her trial in 2012, citing the marital communications privilege in state law. Raymundo was beaten and stabbed nearly 20 times in her Stamford condominium. The three worked together at Stamford- based pharmaceutical company Purdue Pharma.
12/31/15 - EISAI COMPLETES ACQUISITION OF CHINESE GENERIC PHARMACEUTICAL COMPANY LIAONING TIANYI BIOLOGICAL PHARMACEUTICAL
Release date- 28122015- Eisai Co., Ltd. announced today that regarding the acquisition of Chinese generic pharmaceutical company Liaoning TianYi Biological Pharmaceutical Co., Ltd. previously announced on November 27, 2015, the conditions of transfer have been arranged, including receiving a new business license from the regulatory authority in Chi
12/31/15 - Essilor Pharmaceuticals Partnering 2010-2015
The report will be delivered in PDF format within 3 working days of receipt of order. If print or CD-Rom version purchased, the report will be sent by courier using express service. The Partnering Agreements with Essilor 2010-2015 report provides an in-depth insight into the partnering interests and activities of one of the worlds leading biophar
12/31/15 - FDA awards stem cell co Pluristem orphan drug status [Globes, Tel Aviv, Israel]
Dec. 31 Israeli placenta-based cell therapy developer Pluristem Therapeutics Ltd. has been awarded orphan drug status by the US Food and Drug Administration for its PLX-PAD cells treatment for severe preeclampsia. We are encouraged by the US FDA designation that demonstrates Pluristem's commitment to the program and the potential promise it holds
12/31/15 - Gilrose Pharmaceuticals Assigned Patent
ALEXANDRIA, Va., Dec. 31 Gilrose Pharmaceuticals, White Plains, New York, has been assigned a patent developed by two co-inventors for "pharmaceutical intervention and method for treating an apraxia of speech in children." The co-inventors are Bruce Roseman, White Plains, New York, and Gilla Kaplan, New York. Written by Amal Ahmed; edited by Jaya
12/31/15 - Global Blood Therapeutics Receives FDA Orphan Drug Designation for GBT440 in Sickle Cell Disease
Global Blood Therapeutics, Inc., a biopharmaceutical company developing novel therapeutics for the treatment of grievous blood-based disorders with significant unmet needs, announced today that the U.S. Food and Drug Administration has granted orphan drug designation for GBT440 for the treatment of patients with sickle cell disease.
12/31/15 - Global Market Study on Compounding Pharmacies: Regulatory Harmonization and Innovative Therapeutic Areas to Boost Demand for Compounded Drugs
Compounding Pharmacies are pharmacies that produce drugs tailored to needs of individual patients, by altering, combining, or mixing active pharmaceutical ingredients of drugs. Compounded drugs are prepared under prescription from physicians. This Persistence Market Research report examines the Global Compounding Pharmacies Market for the period.
12/31/15 - Industry-financed clinical trials on the rise, as number of NIH-funded trials falls
By a News Reporter-Staff News Editor at Politics& Government Week Since 2006, the number of industry-sponsored clinical trials studying the benefits and harms of medical treatments has risen dramatically, while the number of clinical trials funded by the National Institutes of Health has fallen substantially, according to new Johns Hopkins Bloomb
12/31/15 - Insys Therapeutics, Inc. to Present at J.P. Morgan 34th Annual Healthcare Conference [Khaleej Times (United Arab Emirates)]
-Insys Therapeutics, Inc. today announced that Dan Brennan, Chief Operating Officer, and Darryl Baker, Chief Financial Officer, will present at the J.P. Morgan 34th Annual Healthcare Conference as follows:. About Insys Therapeutics, Inc.Insys Therapeutics is a specialty pharmaceutical company that develops and commercializes innovative drugs and no
12/31/15 - Japan : EISAI completes Acquisition of Chinese Generic Pharmaceutical company Liaoning Tianyi Biological Pharmaceutical Co., Ltd. [TendersInfo (India)]
Eisai Co., Ltd. announced today that regarding the acquisition of Chinese generic pharmaceutical company Liaoning TianYi Biological Pharmaceutical Co., Ltd. previously announced on November 27, 2015, the conditions of transfer have been arranged, including receiving a new business license from the regulatory authority in China, and the acquisition
12/31/15 - LifeSci Capital Initiates Coverage of TetraLogic Pharmaceuticals Corporation
NEW YORK, NY/ ACCESSWIRE/ December 31, 2015/ LifeSci Capital, LLC, a research-driven investment bank with deep domain expertise in the life sciences sector, today announced that it has initiated coverage of TetraLogic Pharmaceuticals, a clinical-stage biopharmaceutical company developing therapies for cancer and infectious diseases.
12/31/15 - Manatee County fire department receives tool to help with heroin overdoses [The Bradenton Herald]
Dec. 30 MANATEE A Manatee County fire department has received a donation of a drug that will help in the fight against opioid overdose deaths. In July 2014, EVZIO became available in the U.S. by prescription and "is the first and only FDA- approved naloxone product specifically indicated for the emergency treatment of known or suspected opioid
12/31/15 - Market Overview on Proliferative Vitreoretinopathy (PVR) Global Clinical Trials Review, H2, 2015, Industry Analysis, Market Forecast to Dominate Pharma Industry
The Report Proliferative Vitreoretinopathy Global Clinical Trials Review, H2, 2015 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants.Albany, NY 12/31/2015 MarketResearchReports.Biz presents this most up-to-date research on "Proliferative Vitreoretinopathy Global Clinical...
12/31/15 - NeuroDerm Announces Start of Patient Enrollment in Phase II Trial of ND0612H for Advanced Parkinsons Disease [Daily Tribune (Bahrain)]
-NeuroDerm Ltd., a clinical stage pharmaceutical company developing drugs for central nervous system disorders, today announced the start of patient enrollment in a first efficacy trial of ND0612H, the companys continuously administered subcutaneous levodopa/carbidopa solution. This treatment is intended to be an alternative to current treatments..
12/31/15 - Northeast Pharma to Raise up to USD54.3 Million in Private Placement of Shares
Deal Type: Equity Offerings Deal Sub Type: Private Placement Deal Country: China Deal Status: Announced Deal Value: 54.3106 USD. Northeast Pharmaceutical Group Co., Ltd, a pharmaceutical company, has announced the private placement of approximately 42,243,405 shares of its common stock, at a price of CNY8.34 per share, to raise gross proceeds of up
12/31/15 - Patent Issued for Accelerated Partial Breast Irradiation with Shielded Brachytherapy Applicator System and Method of Use (USPTO 9211422)
By a News Reporter-Staff News Editor at Women's Health Weekly Hampton University has been issued patent number 9211422, according to news reporting originating out of Alexandria, Virginia, by NewsRx editors. The patent's inventors are Keppel, Cynthia E.; Nazaryan, Vahagn R.. This patent was filed on April 16, 2014 and was published online on Dece
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2017 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415